Name of journal: World Journal of Clinical Urology
ESPS Manuscript NO: 10844
Periodontitis: Tip of the iceberg in chronic kidney disease
Siribamrungwong M et al. Periodontitis and CKD
Monchai Siribamrungwong, Pawadee Chinudomwong
Monchai Siribamrungwong, Pawadee Chinudomwong, Department of Internal Medicine, Lerdsin General Hospital, College of Medicine, Rangsit University, Bangkok 10500, Thailand
Author contributions: Siribamrungwong M and Chinudomwong P contributed to this review.
Correspondence to: Monchai Siribamrungwong, MD, MSc, Department of Internal Medicine, Lerdsin General Hospital, College of Medicine, Rangsit University, Bangkok 10500, Thailand. email@example.com
Telephone: +66-2-3539800 Fax: +66-2-3539756
Received: April 22, 2014 Revised: June 2, 2014
Accepted: July 27, 2014
Prevalence of chronic kidney disease (CKD) population is constantly escalating not only in the industrialised countries but throughout the world. Its significance is tremendous owing to the consequences it brings about, leading to high morbidity and mortality. Strategies to tackle such a world health problem include identifying associated risk factors, co-morbidities, and complications as well as proper management to handle all the addressed issues. Periodontal disease, a treatable infectious state of the dental supporting tissues, is common in CKD patients. Its association with CKD is believed to be in a reciprocal or bi-directional fashion and has been massively studied. This paper, therefore, aims to review the recent evidences pertaining to the association between periodontal disease and a variety of renal maladies. Most of the current evidences collected were performed as cross-sectional studies and clinical trials. Substantial results revealed that periodontal disease contributes remarkably to the chronic systemic inflammatory burden, leading to cardiovascular and cerebrovascular complications, the principal causes of death among the chronic renal disease patients. Furthermore, several studies demonstrated that proper periodontal intervention could help improve the systemic inflammation and even nutritional status among the CKD patients, resulting in better quality of life. Suggestions have been made that periodontal disease be early detected, managed and controlled to, at least, eradicate a source of inflammation in this population. Awareness of such importance should have been drawn from the concerned parties.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
Key words: Periodontitis; Chronic kidney disease; Dialysis; Kidney transplantation; Inflammation
Core tip: Periodontitis is gaining extensive public recognition due to its devastating impact on systemic diseases. Its association with chronic kidney disease is believed to be in a reciprocal or bi-directional fashion and has been massively studied. Designed as review article, vigilant selection of involved literatures was attempted. This paper, thus, illustrates both the supporting and conflicting results of current publications pertaining to the association of the periodontal disease and a variety of renal maladies including glomerular diseases, dialysis and kidney transplant population.
Siribamrungwong M, Chinudomwong P. Periodontitis: Tip of the iceberg in chronic kidney disease. World J Clin Urol 2014; In press
To date, chronic kidney disease is recognised as a significant public health issue[1, 2] because it leads to high morbidity and mortality[3, 4]. Apparently, the number of chronic kidney disease (CKD) population is progressively rising across the world[6, 7]. Globally, CKD affects greater than 50 million people and approximately more than one million of them undergo renal replacement therapy (RRT). Chronic kidney disease poses extensive burdens not only to the inflicted individuals, importantly in terms of quality of life, but also to the society as a whole, especially, in terms of medical care and subsequent costs. Many developed nations spend more than 2%–3% of their annual health-care budget to provide treatment for end-stage renal disease (ESRD) individuals. For instance, a study in the United States revealed that total management cost of CKD alone was $8000 per patient. Yet, if CKD – related co-morbidities exist, the cost of care rose to $14000. In 2007, the United States Medicare expenditures on CKD patients exceeded $60 billion, representing 27% of the total Medicare budget. Likewise, in England, the National Health Service (NHS) disclosed that the annual cost of medical care in kidney disease was about the same amount as those of the Americans. The estimated cost of English CKD patients was about one-third of all NHS expenditure and more than a half of the sum was spent on RRT.
As a result, it is important that all modifiable risk factors for CKD be identified and controlled such as blood pressure, blood glucose level, and calcium or phosphorus level. Moreover, there is a significantly non-traditional risk factor, chronic systemic inflammation, in which its source should be identified and treated.
Periodontal disease (PD), a treatable infection of the oral cavity, is gaining more attention nowadays. Periodontal disease per se serves as a “source of social inequality, reduced quality of life, reduced chewing function, aesthetic impairment, tooth loss and disability”. In relation to other diseases, a large number of studies have been carried out to demonstrate its association with numerous systemic diseases such as cardiovascular disease, CKD[5, 14, 15], ESRD, glomerulonephritis (GN), diabetes mellitus (DM), rheumatoid arthritis[15, 19], chronic obstructive pulmonary disease (COPD), cognitive impairment, obesity and cancer.
In relation to the chronic kidney disease, evidences have shown an increased rate of periodontal disease in this population group, which is probably owing to the state of inflammation and malnutrition. Observed prevalence of PD in CKD is globally elevated and is noted as the fourth most costly disease to manage in the developed countries. Several studies evidently demonstrated that the CKD patients suffered more from the PD than its healthy counterpart. For instance, one study revealed a 100% prevalence of mild to moderate gingivitis in CKD subjects as compared to 85% in general population. Similarly, an investigation done in the United States by the Third National Health and Nutrition Survey (NHANES III) disclosed an increased prevalence of moderate periodontitis (14.6%) among CKD individuals in comparison with the control group (8.7%)[22, 23].
Moreover, some retrospective and prospective studies have shown a remarkable association between periodontitis and mortality in CKD subjects, even after adjustment for various confounders such as age and smoking. The studies revealed a notably increase in mortality rate of CKD patients with periodontitis of particularly moderate-to-severe degree[20, 24]. Because of the mentioned significance, this paper aims to review the recent evidences pertaining to the close association between periodontal diseases and the chronic kidney disease.
Chronic kidney disease is defined as a condition where there is persistent kidney damage along with progressive and irreversible renal function loss[25-27] through such mechanisms as “renal hyperfiltration, increased intra-glomerular pressure, arterial hypertension, renin-angiotensin system activation, proteinuria and renal ischaemia”. Diagnostic criteria for CKD involve either presence of declined glomerular filtration rate (GFR) or markers of renal damage such as albuminuria, abnormal urine sediment, electrolyte or structure and histology for three or more months as well as history of kidney transplantation.
Currently, the National Kidney Foundation’s Kidney Disease Outcome Quality Initiative’s (KDOQI) classified CKD into five stages according to the severity of condition. In this sense, microalbuminuria represents the degree of renal damage and measured GFR signifies reduced renal function. Simply put, CKD is classified based on Cause, GFR category, and Albuminuria category (referred to as CGA).
Periodontal disease is a group of infectious diseases affecting the dental supporting tissues[29-31], characterised by the progressive destruction of the tooth supporting apparatus[13, 15, 32]. Commonly noted signs of periodontal disease comprise of “gum tenderness, gum bleeding, gum recession, alveolar bone loss, tooth mobility, and tooth loss”.
Periodontal diseases are derived from the microflora formed in the biofilm or dental plaque, adhering to the teeth. Significantly, periodontal pathogens are capable of invading the dental superficial tissue (gingiva) to the deeper structure (bone and ligament)[16, 30, 31]. They contribute to chronic systemic inflammatory burden by causing both local infection and disseminating into the bloodstream, leading to bacteraemia[13, 29]. Inflammatory cascade is, then, activated as clearly seen in an elevation of inflammatory mediators, particularly the C-reactive protein (CRP) and interleukin-6 (IL-6)[5, 18, 29]. As well as adhering to and proliferating in the coronary endothelial cells, resulting in formation, maturation and exacerbation of atheroma, platelet aggregation and vasculature relaxation impairment[13, 14, 34]. These mechanisms, eventually, ensue atherosclerotic complications, the primary cause of high morbidity and mortality among the CKD population[5, 33].
Classification of periodontal disease encompasses plaque-induced gingivitis, chronic and aggressive periodontitis. Plaque-induced gingivitis involves only tissue of the gingivae, characterised by gingival erythema, oedema, haemorrhage and tissue enlargement. It is treatable and reversible, in contrast to the other two conditions. Pathogenesis of periodontitis includes reduced salivary production. As well as increased salivary pH and salivary urea concentration, shift of normal oral flora from Gram–positives to Gram–negatives and secondary hyperparathyroidism of which role is yet proved.
ASSOCIATION BETWEEN PERIODONTITIS AND KIDNEY DISEASES
Chronic kidney disease and periodontitis
Several studies have established the relationship between systemic diseases, including CKD, and the oral disease as an association rather than causal relationship[14, 16, 33, 35, 36]. Many described that linkage between the two entities is in a bidirectional[29, 30] or a reciprocal fashion[5, 27]. That is, CKD and RRT, in any form, can exert an effect on oral tissues as well as dental management among these individuals. Periodontitis, likewise, puts in greatly to the overall systemic inflammatory burden and the management of the ESRD patients.
A large survey study including 11200 adults, demonstrated the bidirectional relationship between periodontal disease and CKD. Multivariable logistic regression models were used to evaluate the direct effect of periodontal disease on the CKD while simultaneously controlling for direct effect of many other factors such as diabetes, hypertension, and socioeconomic status. Adults with periodontal disease and edentulous adults were approximately twice as likely to have CKD (odd ratio = 1.62 and 1.83, respectively) after adjusting for 14 other potential risk factors. Moreover, periodontal disease score was statistically important, such that for every one unit increase in the continuous periodontal disease score, the odds of having CKD increased by one percent when adjusting for the other factors.
Impact of chronic renal disease on periodontal tissues
Numerous studies have agreed on the fact that ESRD patients neglect or pay less attention to dental care, access and utilise less of dental resources and procedures; hence, present with poor oral hygiene. This was attributed largely by immense physical and psychological burden and time–consuming RRT sessions. Furthermore, confounding factors, for instance, DM, smoking, dialysis vintage, age, degree of medical management of renal failure complications, demographic variables, may potentially impact the dental care search. Impact of CKD and RRT was identified on oral tissues such as xerostomia, delayed tooth eruption, enamel hypoplasia and altered salivary pH[5, 30, 33, 34]. The tongue and salivary glands are as well affected (Table 1).
Frequent oral problem is cyclosporine-induced gingival hyperplasia among the RRT patients particularly renal transplantation[5, 31, 34]. In ESRD on haemodialysis (HD) patients, there were elevated level of plaque and calculus, gingival inflammation, and increased tendency and severity of periodontal disease. Uremic state was considered an important underlying cause of the mentioned state, along with immune system alteration and disturbances, and hence, reducing the host response[2, 5, 31]. In pre-dialysis population, a study in Sweden was performed in 51 subjects presented with a variety of CKD, close to dialysis commencement. These participants were given comprehensive dental inspection and the results undoubtedly revealed poor oral health in these ESRD individuals.
Nevertheless, not all studies came across with similar findings with regards to extent and severity of periodontitis among the CKD population. In recent literatures, conflicting study results were reported. Many studies published in some of Asian, North and South American countries -Taiwan, Canada, United States and Brazil- demonstrated a higher prevalence of periodontitis in CKD and higher frequency of chronic severe periodontitis among HD patients. On the contrary, both cross–sectional and clinical trial studies from some the European countries such as Spain and the Netherland found no statistically significant association between periodontitis and HD patients, as compared to the healthy control group.
In the same way, investigation of the association of CKD and periodontal diseases did not show uniform findings even though performed in the same various ethnic groups. In a cross-sectional study among non-Hispanic blacks and whites, those with low income and lower educational level, the authors observed a strongest association between periodontal disease and CKD among the non-Hispanic whites and the low income population after adjustment of such variables as age, race or ethnicity, diabetes and dental care use. In contrast, other studies done in the same ethnicity as above reported that such an association in non-Hispanic whites was unremarkable as compared to the Mexican–Americans and non–Hispanic black CKD patients.
Impact of periodontal diseases on chronic kidney disease
The appreciable influence of periodontal disease on CKD was amplified by systemic inflammatory burden[5, 31, 33-35]. Periodontal pathogens were able to not only cause the local inflammatory reaction but also invade into the bloodstream and cause bacteraemia[33, 34]. Inflammatory process involves induction of several acute–phase mediators, such as elevated CRP, blood sugar and low–density lipoprotein (LDL) level as well as declining high-density lipoprotein (HDL) level and peripheral neutrophil counts and function. This, afterwards, activates the inflammatory cascade. Activation of the complement system, accumulation of pathogens in the vascular endothelium, atheroma formation and impaired vascular relaxation are all involved in the pathogenesis of atherosclerosis[13, 14, 35]. Subsequently, this leads to the final events of myocardial infarction and cerebrovascular accident, the primary causes of death in CKD patients[5, 33].
Vastly mentioned, a greater number of pathogens were found in HD patients. Porphyromonas gingivalis is one of those species playing vital roles in bringing about such serious outcomes in these populations. A further study regarding major periodontal pathogens and their severity among CKD patients as compared to systemically healthy controls was done in Brazil. Sixty-six eligible chronic periodontitis patients comprised of 19 healthy, 25 pre-dialysis CKD, and 22 ESRD patients receiving RRT treatment were included. These patients underwent periodontal assessment in terms of periodontal pocket depth (PPD), gingival recession, and clinical attachment loss (CAL). Subgingival plaque was collected and, then, analysed by the polymerase chain reaction method. The findings suggested higher severity of periodontitis in CKD patients as compared to their counterparts. Eikenella corrodens was the most prevalent periodontal pathogen found in parallel between the control and pre-dialysis groups. Conversely, the RRT group observed the outnumbered P. Gingivalis, Candida albicans was of no less importance in the CKD population as it often predisposes these individuals to opportunistic infections, signifying that administration of anti–fungal agent when chronic periodontitis occurred is crucial. Interestingly, another clinical trial demonstrated that, in comparison with the healthy controls, the CKD participants exhibited more sites of therapy non-responsive species than its counterpart, and periodontal treatment affected fewer species.
Aside from being the source of inflammation and infection, poor oral health state may act as a contributor to protein–energy wasting in CKD population. It presents as anorexia, muscle atrophy, low anabolic hormones, insulin resistance and raised energy expenditure through a number of pathways. A variety of medications taken in CKD patients produces xerostomia which, sequentially, causes deglutition problem. Metallic taste is also reported in one-third of advanced CKD individuals, affecting the perception of food and leading to diminished nutrient intake. Poor oral hygiene, likewise, acts as a contributor to cardiovascular complications in CKD as a by-product of the inflammatory cascade.
Recently, a systematic review evaluating the association between periodontitis and chronic kidney disease as well as the effect of periodontal treatment on the estimated GFR was published. Four cross-sectional studies, one retrospective and three interventional studies were included. From four observational studies, the correlation between periodontitis and CKD was demonstrated along with an odd ratio of 1.95 (1.35-2.01) by pooled estimates. Interestingly, all interventional studies reported a positive effect of periodontal therapy on estimated GFR. Unfortunately, the reviewer critiqued on the report that this was not a well conducted systematic review. The main results were buried in abundant and mostly superfluous verbiage.
Glomerular diseases and periodontitis
In contrast to frequent studies on the association between periodontitis and CKD, limited studies in GN haves been mentioned. Ardalan et al reported the preliminary study of the association, recruiting 10 subjects with unknown primary GN (7 mesangioproliferative GN, 2 membranoproliferative GN and 1 of unknown origin). Severity of the periodontal disease was determined by plaque index (PI), gingival index (GI) and PPD. All received appropriate dental treatment after initial examination. After therapy, median urine protein excretion was reduced significantly from 3100 to 900 mg/day (P = 0.008), and 40 percent of the patients was found to have decreased CRP level. The study reported a high rate of periodontal disease through such mechanisms as direct glomerular invasion by periodontal pathogens and indirect systemic inflammatory burden of CRP. The authors, therefore, concluded that the association between periodontitis and primary GN was plausible. In addition, another comprehensive study analysed tonsil flora in immunoglobulin A nephropathy (IgAN) patients, the most common of primary glomerular disease. Sixty-eight IgAN patients against 28 controls were enrolled, by employing denaturing gradient gel electrophoresis methods. Treponema spp. or Campylobacter rectus, anaerobic bacteria reported to be causative agents of periodontal diseases, played a remarkable role in the remission of proteinuria (hazard ratio 2.35, P = 0.019), by which the IgAN subjects were found to have a higher incidence than those without these organisms.
By far, a common secondary glomerular disease is diabetic nephropathy, a complication of longstanding diabetes. DM is an unequivocally major risk factor of periodontitis. Commonly, the risk of periodontitis is increased about three times in diabetic as compared with non-diabetic populations. Level of glycaemic control was determined as a key risk indicator. The poorer the HbA1C presented among diabetic patients, the higher the risk of developing periodontitis. This, in turn, may predict the development and progression of ESRD itself. Diabetic nephropathy patients possessed worse dental health, in terms of more dental caries and deep periodontal pockets, as well as lower salivary secretion. These patients also tended to have higher observed yeast counts, predisposing to the oral candidiasis.
A study in the Gila River Indian community with type 2 DM investigated the effect of periodontitis on development of macroalbuminuria or ESRD. Sixty percent of the subjects had moderate to severe periodontitis and 20 percent were edentulous at baseline and during follow-up period. Thirty-six percent developed macroalbuminuria and about 13 percent progressed to ESRD. Interestingly, the incidence of macroalbuminuria and ESRD was elevated as the degree of periodontitis progressed; thus, predicted the development of overt diabetic nephropathy and ESRD in a “dose-dependent” manner. A similar study in Pima Indians with type 2 DM was performed. The relationship between number of deaths per 1000 person and years of follow-up was increasing along the continuum from none/mild, moderate to severe periodontitis, respectively. After adjustment for age, sex, duration of DM, HbA1C, macroabuminuria, body mass index, serum cholesterol, hypertension, electrocardiographic abnormalities and current smoking status, patients with severe periodontitis had 3.2 times the risk of cardio-renal mortality (ischemic heart disease and diabetic nephropathy combined) compared with the other two counterparts.
Dialysis and periodontitis
Major changes in the oral condition usually accompany the initiation of dialysis. Studies have illustrated higher rates of oral pathology in dialysis patients, presenting with one or more of the oral manifestations. Oral features include uremic odour, dry mouth, taste disturbance, tongue coating, mucosal petechiae and ecchymosis, reduced salivary flow, mucosal inflammation and oral ulceration[5, 16, 35]. Progression of periodontal disease has been reported as severity increases along the continuum from pre-dialysis, peritoneal dialysis (PD) to HD. Yet, study about prevalence of these symptoms between PD and HD patients is still sparse.
A study in Poland compared the periodontal status between three adult CKD groups, those on maintenance HD, continuous ambulatory peritoneal dialysis (CAPD), and pre-dialysis treatment group. The study involved 202 dialysis patients (141 on HD and 61 on CAPD), and 160 CKD patients (35 on HD, 33 on CAPD and 38 pre-dialysis). Two control groups were allocated: a group of 26 healthy individuals with advanced periodontitis and 30 individuals from the general population. The severity of periodontal disease was clinically measured by the GI, papillary bleeding index (PBI), PI, CAL and community periodontal index of treatment needs (CPITN). HD patients revealed the most concerning values in all parameters of periodontal disease severity. A study in Brazil done in the same three groups as above revealed that the pre-dialysis, as compared to the CAPD and HD, subjects showed a higher bleeding on probing (BOP) and frequency of generalised chronic periodontitis, which was enhanced by smoking. Pre-dialysis and HD groups paralleled in such findings as having higher frequency of severe chronic periodontitis and percentage of sites with CAL> 6 mm. Due to the heterogeneity of data, PD seems to have a higher prevalence of periodontal disease than the general healthy population, but lower than the HD population. Conversely, CAPD patients and systemically healthy individuals appeared to share similarity in the periodontal conditions.
In Turkey, many studies were performed. One study revealed that GI, PI and calculus surface index (CSI) were significantly higher in PD and HD groups than the healthy controls. What’s more, PD patients presented with higher salivary flow rate (SFR), salivary pH (SpH), salivary buffering capacity (SBC), decayed, missing, and filled teeth (DMFT) index and numbers of filled teeth than the HD counterparts. Another study on relationship between periodontitis and risk of atherosclerosis was published. The authors evaluated periodontal status of 110 eligible PD patients by using PI, GI and periodontal disease index (PDI). Besides, the atherosclerotic risk, nutritional and inflammatory markers were assessed. There found an association between poor periodontal status and parameters of malnutrition, inflammation and atherosclerotic risk factors. Multiple regression analysis demonstrated that age, albumin level and duration of dialysis were independently associated with the severity of periodontitis. This study consequently confirmed the relationship between both periodontitis and non-surgical periodontal treatment and chronic systemic inflammation.
Recently, a study conducted in Thailand, clinical periodontal status was evaluated in 32 stable PD patients by PI and PDI. At baseline, high sensitivity CRP positively correlated with clinical periodontal status (PI; r = 0.57, P < 0.01 and PDI; r = 0.56, P < 0.01). After completion of periodontal therapy, clinical periodontal indexes were significantly lower and CRP significantly decreased from 2.93 to 2.21 mg/dL. In addition, increased BUN, from 47.33 to 51.8 mg/dL, reflected nutritional status improvement. Erythropoietin dosage requirement decreased from 8000 to 6000 units/wk while hemoglobin level remained stable. The authors, hence, concluded that periodontitis is a potential treatable source of systemic inflammation in PD patients and periodontal treatment can improve systemic inflammation, nutritional status and erythropoietin responsiveness among these patients.
Among the three modalities of renal replacement therapy - HD, PD and kidney transplantation (KT); haemodialysis is the most common form deployed among ESRD adult patients. ESRD patients, particularly those on maintenance HD, are at great risk of cardiovascular complications, resulting in high morbidity and mortality[5, 49]. In the United States, atherosclerotic events were reported as the leading cause, accounting for 44 percent of all deaths among the ESRD individuals, followed by infection.
To support this, a prospective observational study was performed in Taiwan, aiming to investigate the relationship between the periodontitis and CVD mortality in HD patients. Involved 253 HD patients’ dental health status was indicated by three methods of examination, namely, PI, GI and PDI. After a 6-year follow up period, the subjects with moderate-to-severe periodontitis were found at greater risk of having (1.83-fold) increased CVD-related mortality, even after adjustment of various confounders such as age, smoking and educational level. Similarly, with the same objective as above, a retrospective analysis was carried out in the United States One hundred and sixty-eight adults were recruited and given dental examination in search for periodontal disease. After 18 mo of follow-up, the study concluded that HD subjects with moderate-to-severe periodontitis encountered a 5-fold increase in CVD death. Adjustment for other co-variables did not significantly affect such a strong association between the two conditions.
Aside from that, 253 Taiwanese haemodialysis subjects were included in a study to investigate the adverse effect of periodontitis on inflammation and malnutrition status of these patients. Three methods of assessment included PI, GI and PDI. Data on demography such as age and sex, biochemistry such as BUN, Cr, CRP, albumin and ferritin, and haematology were collected for analysis. The results conclusively revealed significant prevalence of periodontitis among the studied patients. Not only that these individuals were facing an elevated risk of cardiovascular impediment, they also encountered a state of protein–energy malnutrition. Increased degree of inflammation was observed from elevated levels of serum ferritin and CRP. The authors strongly believed that association between clinical periodontal status and systemic inflammation exists. Accordingly, effective periodontal management could result in CRP reduction and might imply a lower level of risk in developing systemic complications in this population although decreased cardiovascular complications remained to be further explored.
As well, most studies about the effect of periodontal treatment in HD population showed positive effect on inflammation[27, 50-53]. What’s more, the effect of periodontal therapy in 30 stable HD patients demonstrated the significant improvement of clinical periodontal status (both PI and PDI), nutritional markers (pre-dialysis BUN and serum albumin) and erythropoietin responsiveness after completion of treatment. Nevertheless, some studies failed to show this effect. An example was a randomised controlled trial investigating an effect of intensive periodontal therapy on metabolic and inflammatory markers in 342 dialysis patients. The study illustrated insignificant difference between the treated and control groups for serum albumin or IL-6 level at any time when adjusted for body mass index, diabetes and PI. The limitation of the study involved small sample size, only 53 randomly assigned patients, the relatively healthy subjects, and imbalance in diabetes.
Kidney transplantation and periodontitis
Kidney transplantation (KT) is the most efficient and preferred choice of long-term RRT despite disadvantages such as risk of opportunistic infection, graft-versus-host rejection, hypertension, and the tendency of reduce renal function with age advancement[5, 55].
Gingival hyperplasia is a notable condition observed among the renal transplant patients, secondary to post-transplantation immunosuppressive agents such as cyclosporine and prednisolone. Primarily, dose-dependent cyclosporine was said to be the focal cause of this incidence. Additional use of calcium channel blockers like nifedipine may enhance the incidence and accelerate the severity of gum overgrowth. This can be successfully reduced by substitution with tacrolimus and surgical intenvention. An attempt to evaluate the linkage between the KT and oral lesions was carried out, including 33 renal transplant patients, 46 dialysed patients and 37 control populations. All subjects were intra-orally examined and oral findings were identified and treated. Similarly, gingival overgrowth was the most prevalent finding among the KT patients, resulting from cyclosporine administration either alone or in combination with the calcium channel blockers. Other frequent findings comprised of xerostomia, geographic tongue, and oral candidiasis. Metallic taste was observed more in dialysis patients. In sum, the prevalence of oral lesions was superior in the renal disease patients.
Investigation about the association between periodontal status and renal allograft function, estimated by GFR, was carried out in the United States. KT patients were categorised into two groups: deterioration or stable/improvement of renal function between two points of time, at least six months apart. Chronic periodontitis, defined by ≥ 6 probing depth > 5 mm, or clinical attachment level > 4 mm in at least six proximal sites, was significantly more prevalent in patients with deteriorated renal function (P = 0.04). It acted as a statistically significant predictor of improved renal function overtime (P = 0.04). Interestingly, impact of chronic periodontitis on other cardiovascular conditions, among these individuals was further studied. A study from Poland illustrated this when it aimed to assess whether periodontitis may contribute to left ventricular hypertrophy (LVH) in KT patients. Ninety-nine patients were classified according to CPITN score into patients with advanced disease (CPITN 3-4) and none/moderate lesions (CPITN 0-2). The advanced lesion group had higher plasma high-sensitivity CRP concentration (P < 0.05) and left ventricular mass index (LVMI) (P < 0.001), compared with the other group. Besides, LVMI was dependent on CPITN (P < 0.001), high-sensivity CRP (P < 0.05), serum cholesterol (P < 0.05) and Cr levels (P < 0.05). The authors summarized that chronic periodontitis and concomitant systemic inflammatory reaction in KT patients may be associated with LVH.
Finally, inflammation is recognised as playing a pivotal role in transplant rejection. CRP and IL-6, significant inflammatory markers, are documented as surrogate markers to identify patients who are at greater risk for rejection. In this light, a hypothesis was proposed that periodontitis may increase the risk of organ rejection by contributing to the systemic inflammation load in organ transplant patients. A study about the link between periodontitis and serum IL–6 was performed in 47 transplant patients and 18 healthy age-matched controls. The result demonstrated significantly higher level of serum IL-6 and increased mean probing depth in transplant patients. Multivariable linear regression analysis, after adjusted for gender, diabetes, smoking and immunosuppressant dosage, showed that the mean probing depth, number of missing teeth and mean percentage of sites with at least 4 mm of attachment loss were independent predictors for elevated serum IL-6 level. Besides, a study with a larger group of subjects (90 transplant patients compared with 72 age-matched controls) reported a higher level of IL-6 and CRP in transplant individuals, compared to the control group.
Current literatures strongly supported the association between the periodontal disease and the chronic kidney diseases. They affect each other reciprocally. Periodontal disease, a treatable infective dental condition, potentially posed devastating chronic systemic inflammatory burdens to the CKD population, resulting in significant atherosclerotic complications and death. In the same way, chronic renal disease impacted the oral health in this population with gingival overgrowth as the most prevalent finding due to cyclosporine mediated mechanism. Several studies believed that proper periodontal intervention rendered a promising outcome of the systemic improvement in CKD subjects although its impact on cardiovascular complications remained to be further explored. Thus, its diagnosis and management deserve better awareness. Further investigation especially the prospective randomised-control trial with intervention should be conducted to allow more accurate evaluation. Also, a larger number of participants and ethnic subgroups recruited in the research are required to allow a bigger picture of comparison and conclusion.
1 Artese HP, de Sousa CO, Torres MC, Silva-Boghossian CM, Colombo AP. Effect of non-surgical periodontal treatment on the subgingival microbiota of patients with chronic kidney disease. Braz Oral Res 2012; 26: 366-372 [PMID: 22714926]
2 Ioannidou E, Swede H. Disparities in periodontitis prevalence among chronic kidney disease patients. J Dent Res 2011; 90: 730-734 [PMID: 21422478 DOI: 10.1177/0022034511402209]
3 Vilela EM, Bastos JA, Fernandes N, Ferreira AP, Chaoubah A, Bastos MG. Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) 2011; 66: 657-662 [PMID: 21655762 DOI: 10.1590/S1807-59322011000400022]
4 Hauser AB, Stinghen AE, Gonçalves SM, Bucharles S, Pecoits-Filho R. A gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clin Pract 2011; 118: c165-c72; discussion c172 [PMID: 21160227 DOI: 10.1159/000321438]
5 Craig RG. Interactions between chronic renal disease and periodontal disease. Oral Dis 2008; 14: 1-7 [PMID: 18173441 DOI: 10.1111/j.1601-0825.2007.01430.x]
6 Vesterinen M, Ruokonen H, Furuholm J, Honkanen E, Meurman JH. Oral health in predialysis patients with emphasis on diabetic nephropathy. Clin Oral Investig 2011; 15: 99-104 [PMID: 20084416 DOI: 10.1007/s00784-009-0360-7]
7 Strippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D, Hegbrant J, Wollheim C, Gargano L. Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. BMC Nephrol 2013; 14: 90 [PMID: 23597063 DOI: 10.1186/1471-2369-14-90]
8 Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl 2005; : S1-S6 [PMID: 16108963]
9 Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13 Suppl 1: S37-S40 [PMID: 11792760]
10 Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-1270 [PMID: 21993585]
11 Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300-1306 [PMID: 15100370 DOI: 10.1097/01.ASN.0000125670.64996.BB]
12 Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 2012; 27 Suppl 3: iii73-iii80 [PMID: 22815543]
13 Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013; 40 Suppl 14: S24-S29 [PMID: 23627332 DOI: 10.1111/jcpe.12089]
14 Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR. Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 711-717 [PMID: 21350109 DOI: 10.2215/CJN.08270910]
15 Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Periodontol 2013; 84: S8-S19 [PMID: 23631586 DOI: 10.1902/jop.2013.1340010]
16 Ariyamuthu VK, Nolph KD, Ringdahl BE. Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review. Cardiorenal Med 2013; 3: 71-78 [PMID: 23802000 DOI: 10.1159/000350046]
17 Ardalan MR, Ghabili K, Pourabbas R, Shoja MM. A causative link between periodontal disease and glomerulonephritis: a preliminary study. Ther Clin Risk Manag 2011; 7: 93-98 [PMID: 21445283 DOI: 10.2147/TCRM.S14106]
18 Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, Knowler WC, Nelson RG. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 2007; 30: 306-311 [PMID: 17259499]
19 Otomo-Corgel J, Pucher JJ, Rethman MP, Reynolds MA. State of the science: chronic periodontitis and systemic health. J Evid Based Dent Pract 2012; 12: 20-28 [PMID: 23040337 DOI: 10.1016/S1532-3382(12)70006-4]
20 Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int 2009; 75: 746-751 [PMID: 19165177 DOI: 10.1038/ki.2008.660]
21 Ruospo M, Palmer SC, Craig JC, Gentile G, Johnson DW, Ford PJ, Tonelli M, Petruzzi M, De Benedittis M, Strippoli GF. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant 2014; 29: 364-375 [PMID: 24081863 DOI: 10.1093/ndt/gft401]
22 Manjunath N, Sahana, Nanaiah P. Prevalence of Periodontitis in Hemodialysis Patients. J Dent and Med Sci 2013; 6: 1-5
23 Sharma P, Dietrich T, Sidhu A, Vithlani V, Rahman M, Stringer S, Jesky M, Kaur O, Ferro C, Cockwell P, Chapple IL. The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results. J Clin Periodontol 2014; 41: 653-661 [PMID: 24738870 DOI: 10.1111/jcpe.12263]
24 Chen LP, Chiang CK, Peng YS, Hsu SP, Lin CY, Lai CF, Hung KY. Relationship between periodontal disease and mortality in patients treated with maintenance hemodialysis. Am J Kidney Dis 2011; 57: 276-282 [PMID: 21177012 DOI: 10.1053/j.ajkd.2010.09.016]
25 Iwasaki M, Taylor GW, Manz MC, Kaneko N, Imai S, Yoshihara A, Miyazaki H. Serum antibody to Porphyromonas gingivalis in chronic kidney disease. J Dent Res 2012; 91: 828-833 [PMID: 22828790 DOI: 10.1177/0022034512455063]
26 Bastos JA, Diniz CG, Bastos MG, Vilela EM, Silva VL, Chaoubah A, Souza-Costa DC, Andrade LC. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. Arch Oral Biol 2011; 56: 804-811 [PMID: 21211789 DOI: 10.1016/j.archoralbio.2010.12.006]
27 Yazdi FK, Karimi N, Rasouli M, Roozbeh J. Effect of nonsurgical periodontal treatment on C-reactive protein levels in maintenance hemodialysis patients. Ren Fail 2013; 35: 711-717 [PMID: 23534529 DOI: 10.3109/0886022X.2013.777890]
28 Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-830 [PMID: 23732715 DOI: 10.7326/0003-4819-158-11-201306040-00007]
29 Fisher MA, Borgnakke WS, Taylor GW. Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 519-526 [PMID: 20948377 DOI: 10.1097/MNH.0b013e32833eda38]
30 Ismail G, Dumitriu HT, Dumitriu AS, Ismail FB. Periodontal disease: a covert source of inflammation in chronic kidney disease patients. Int J Nephrol 2013; 2013: 515796 [PMID: 23840952 DOI: 10.1155/2013/515796]
31 Craig RG, Kotanko P, Kamer AR, Levin NW. Periodontal diseases--a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy? Nephrol Dial Transplant 2007; 22: 312-315 [PMID: 17071738]
32 Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis 2006; 47: 815-822 [PMID: 16632020]
33 Madore F. Periodontal disease: a modifiable risk factor for cardiovascular disease in ESRD patients? Kidney Int 2009; 75: 672-674 [PMID: 19282857 DOI: 10.1038/ki.2009.15]
34 Fisher MA, Taylor GW, West BT, McCarthy ET. Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int 2011; 79: 347-355 [PMID: 20927035 DOI: 10.1038/ki.2010.384]
35 Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol 2011; 6: 218-226 [PMID: 21115624 DOI: 10.2215/CJN.05470610]
36 Wahid A, Chaudhry S, Ehsan A, Butt S, Ali Khan A. Bidirectional Relationship between Chronic Kidney Disease & amp; Periodontal Disease. Pak J Med Sci 2013; 29: 211-215 [PMID: 24353542]
37 Buhlin K, Bárány P, Heimbürger O, Stenvinkel P, Gustafsson A. Oral health and pro-inflammatory status in end-stage renal disease patients. Oral Health Prev Dent 2007; 5: 235-244 [PMID: 17977296]
38 Chambrone L, Foz AM, Guglielmetti MR, Pannuti CM, Artese HP, Feres M, Romito GA. Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. J Clin Periodontol 2013; 40: 443-456 [PMID: 23432795 DOI: 10.1111/jcpe.12067]
39 Borgnakke WS. Periodontitis may be associated with chronic kidney disease, but current evidence is insufficient. J Evid Based Dent Pract 2013; 13: 88-90 [PMID: 24011000 DOI: 10.1016/j.jebdp.2013.07.002]
40 Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y. Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment. PLoS One 2014; 9: e81636 [PMID: 24489644 DOI: 10.1371/journal.pone.0081636]
41 Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012; 55: 21-31 [PMID: 22057194 DOI: 10.1007/s00125-011-2342-y]
42 Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, Shlossman M, Bennett PH, Genco R, Knowler WC. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005; 28: 27-32 [PMID: 15616229 DOI: 10.2337/diacare.28.1.27]
43 Borawski J, Wilczyńska-Borawska M, Stokowska W, Myśliwiec M. The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients. Nephrol Dial Transplant 2007; 22: 457-464 [PMID: 17124280 DOI: 10.1093/ndt/gf1676]
44 Brito F, Almeida S, Figueredo CM, Bregman R, Suassuna JH, Fischer RG. Extent and severity of chronic periodontitis in chronic kidney disease patients. J Periodontal Res 2012; 47: 426-430 [PMID: 22181057 DOI: 10.1111/j.1600-0765.2011.01449.x]
45 Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Besler M, Trablus S, Issever H, Yildiz A. Evaluation of periodontal parameters in patients undergoing peritoneal dialysis or hemodialysis. Oral Dis 2008; 14: 185-189 [PMID: 18302680 DOI: 10.1111/j.1601-0825.2007.01372.x]
46 Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Issever H, Yildiz A. Oral health and inflammation in patients with end-stage renal failure. Perit Dial Int 2009; 29: 472-479 [PMID: 19602614]
47 Cengiz MI, Bal S, Gökçay S, Cengiz K. Does periodontal disease reflect atherosclerosis in continuous ambulatory peritoneal dialysis patients? J Periodontol 2007; 78: 1926-1934 [PMID: 18062114]
48 Siribamrungwong M, Yothasamutr K, Puangpanngam K. Periodontal treatment reduces chronic systemic inflammation in peritoneal dialysis patients. Ther Apher Dial 2014; 18: 305-308 [PMID: 24118730 DOI: 10.1111/1744-9987.12105]
49 Craig RG, Kotanko P. Periodontitis and the end-stage renal disease patient receiving hemodialysis maintenance therapy. Compend Contin Educ Dent 2009; 30: 544, 546-552 [PMID: 19824568]
50 Siribamrungwong M, Puangpanngam K. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients. Ren Fail 2012; 34: 171-175 [PMID: 22229644 DOI: 10.3109/0886022X.2011.643351]
51 Artese HP, Sousa CO, Luiz RR, Sansone C, Torres MC. Effect of non-surgical periodontal treatment on chronic kidney disease patients. Braz Oral Res 2010; 24: 449-454 [PMID: 21180967]
52 Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008; 35: 277-290 [PMID: 18294231 DOI: 10.1111/j.1600-051X.2007.01173.x]
53 Freitas CO, Gomes-Filho IS, Naves RC, Nogueira Filho Gda R, Cruz SS, Santos CA, Dunningham L, Miranda LF, Barbosa MD. Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci 2012; 20: 1-8 [PMID: 22437670]
54 Wehmeyer MM, Kshirsagar AV, Barros SP, Beck JD, Moss KL, Preisser JS, Offenbacher S. A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study. Am J Kidney Dis 2013; 61: 450-458 [PMID: 23261122 DOI: 10.1053/j.ajkd.2012.10.021]
55 Dirschnabel AJ, Martins Ade S, Dantas SA, Ribas Mde O, Grégio AM, Alanis LR, Ignacio SA, Trevilatto PC, Casagrande RW, de Lima AA, Machado MÂ. Clinical oral findings in dialysis and kidney-transplant patients. Quintessence Int 2011; 42: 127-133 [PMID: 21359247]
56 Ioannidou E, Kao D, Chang N, Burleson J, Dongari-Bagtzoglou A. Elevated serum interleukin-6 (IL-6) in solid-organ transplant recipients is positively associated with tissue destruction and IL-6 gene expression in the periodontium. J Periodontol 2006; 77: 1871-1878 [PMID: 17076613 DOI: 10.1902/jop.2006.060014]
57 Franek E, Blach A, Witula A, Kolonko A, Chudek J, Drugacz J, Wiecek A. Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients. Transplantation 2005; 80: 3-5 [PMID: 16003224 DOI: 10.1097/01.TP.0000158716.12065.24]
58 Ioannidou E, Shaqman M, Burleson J, Dongari-Bagtzoglou A. Periodontitis case definition affects the association with renal function in kidney transplant recipients. Oral Dis 2010; 16: 636-642 [PMID: 20412451 DOI: 10.1111/j.1601-0825.2010.01665.x]
59 Shaqman M, Ioannidou E, Burleson J, Hull D, Dongari-Bagtzoglou A. Periodontitis and inflammatory markers in transplant recipients. J Periodontol 2010; 81: 666-672 [PMID: 20429646]
P-Reviewer: Abundo R, Chang CC, de Oliveira JMF, Friedman EA, Karihaloo A, Wu-Wong JR S-Editor: Wen LL L-Editor: E-Editor:
Table 1 Common oro-facial problems associated with chronic kidney disease itself or caused by therapy
Oral Mucosal Lesions
Metastatic soft tissue calcifications
Macules. Nodules. Papillomas
White patch. Erythematous patch
Angular chelitis /Candidiasis
Oral hairy leukoplakia
Lichen planus-like disease
Epstein-Barr virus like lesions
Poor oral hygiene
Uremic odour, Bad odour/Halitosis
Acute suppurative sialadenitis
Black hairy tongue
Decreased thickness of cortical bone
Abnormal bone healing after extraction
Premature bone loss in the jaw
Brown tumour of the maxilla
Increased deposits of calculus
Severe periodontal destruction
Increased tooth mobility
Premature tooth loss
Erosion of lingual tooth surface